본문 바로가기
bar_progress

Text Size

Close

Possibility of Moderna Vaccine Booster Shot Approval!! Which All-Time Core Stocks Will Benefit??

US FDA Actively Reviewing Approval for Moderna COVID-19 Vaccine Booster Shot!!

Moderna Booster Shot Shows Enhanced Immune Efficacy Against Delta Variant, FDA Clinical Data Submitted!!

Following Nanocovax, even Moderna, an undervalued COVID vaccine beneficiary stock with a potential 1000% increase, ‘This One’! Check it before it’s too late!

Check the TOP 3 mRNA-related stocks that will benefit from the COVID-19 vaccine boom and click TOP 1 to get information and response!


●TOP 3● Ilyang Pharmaceutical (094820): A pharmaceutical company with production facilities capable of manufacturing finished mRNA products. Annual production capacity of 1.4 billion doses, receiving overseas love calls.

●TOP 2● ST Pharm (189860): News of discovering a delta variant-targeted mRNA vaccine and participating in a next-generation mRNA vaccine platform development consortium.

●TOP 1● (***0**) : Ultra-high growth imminent stock, limited to the first 10 people ★Free Disclosure★ ▶Click◀


★Bonus Hidden Stock★ This is it!! Also limited to the first 10 people ▶Check Stock◀


Only a few days left!! It’s going up right away!! Hurry and grab it before it’s too late!!


Possibility of Moderna Vaccine Booster Shot Approval!! Which All-Time Core Stocks Will Benefit??

Cumulative Return Achievement Event! 3 Stocks Achieved Increase Within 2 Days! Free Disclosure to the First 50 People!! ▶Click!◀


[Return Status by Stock]

Doosan Heavy Industries +142% Profit!

KEPCO Engineering & Construction +151% Profit!

Bioneer +169% Profit!

Mad Factor +308% Profit!

ATECTN 130% Profit!

Sang-A Frontec +121% Profit!


[Today’s Stocks of Interest]: Bumyang Geonyeong / iMarketKorea / DSR Steel / Haesung Optics / Egjax


※ This content is unrelated to the editorial direction of Asia Economy, and all responsibility lies with the information provider.


© The Asia Business Daily(www.asiae.co.kr). All rights reserved.


Join us on social!

Top